U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H12O2
Molecular Weight 212.2439
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Benzyl benzoate

SMILES

O=C(OCC1=CC=CC=C1)C2=CC=CC=C2

InChI

InChIKey=SESFRYSPDFLNCH-UHFFFAOYSA-N
InChI=1S/C14H12O2/c15-14(13-9-5-2-6-10-13)16-11-12-7-3-1-4-8-12/h1-10H,11H2

HIDE SMILES / InChI

Molecular Formula C14H12O2
Molecular Weight 212.2439
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: https://en.wikipedia.org/wiki/Benzyl_benzoate http://www.drugbank.ca/drugs/DB00676

Benzyl benzoate is an organic compound with the formula C6H5CH2O2CC6H5. It is the ester of benzyl alcohol and benzoic acid. It forms either a viscous liquid or solid flakes and has a weak, sweet-balsamic odor. It occurs in a number of blossoms (e. g. tuberose, hyacinth) and is a component of Balsam of Peru and Tolu balsam. It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system. Benzyl benzoate is one of the older preparations used to treat scabies. Scabies is a skin infection caused by the mite sarcoptes scabiei. It is characterised by severe itching (particularly at night), red spots, and may lead to a secondary infection. Benzyl benzoate is lethal to this mite and so is useful in the treatment of scabies. It is also used to treat lice infestation of the head and body. Benzyl benzoate is not the treatment of choice for scabies due to its irritant properties. Benzyl benzoate exerts toxic effects on the nervous system of the parasite, resulting in its death. It is also toxic to mite ova, though its exact mechanism of action is unknown. In vitro, benzyl benzoate has been found to kill the Sarcoptes mite within 5 minutes.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Inactive ingredient
BRIGHTENING DYNAMICS TRAVELING KIT JAFRA

Approved Use

Helps prevent sunnburn. If used as directed, with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun.
Curative
BENZYL BENZOATE

Approved Use

Unknown

Launch Date

1976
Curative
BENZYL BENZOATE

Approved Use

Unknown

Launch Date

1976
Doses

Doses

DosePopulationAdverse events​
10 % 1 times / day multiple, topical
Dose: 10 %, 1 times / day
Route: topical
Route: multiple
Dose: 10 %, 1 times / day
Sources:
unhealthy, 4.7 years (range: 6 months - 15 years)
n = 37
Health Status: unhealthy
Condition: Scabies
Age Group: 4.7 years (range: 6 months - 15 years)
Population Size: 37
Sources:
Other AEs: Localised skin reaction...
Other AEs:
Localised skin reaction (12 patients)
Sources:
25 % 1 times / day multiple, topical
Dose: 25 %, 1 times / day
Route: topical
Route: multiple
Dose: 25 %, 1 times / day
Sources:
pregnant, adult
n = 444
Health Status: pregnant
Condition: scabies
Age Group: adult
Sex: F
Population Size: 444
Sources:
AEs

AEs

AESignificanceDosePopulation
Localised skin reaction 12 patients
10 % 1 times / day multiple, topical
Dose: 10 %, 1 times / day
Route: topical
Route: multiple
Dose: 10 %, 1 times / day
Sources:
unhealthy, 4.7 years (range: 6 months - 15 years)
n = 37
Health Status: unhealthy
Condition: Scabies
Age Group: 4.7 years (range: 6 months - 15 years)
Population Size: 37
Sources:
PubMed

PubMed

TitleDatePubMed
New microencapsulated sunscreens: technology and comparative evaluation.
2002 Aug 21
[Determination of volatile constituents in guanxin suhe wan by gas chromatography-mass spectrometry].
2002 Jul
Benzoate X receptors alpha and beta are pharmacologically distinct and do not function as xenobiotic receptors.
2002 Nov 15
[Stereochemistry of the reductive amination of 4-oxoproline derivatives with glycine esters].
2002 Nov-Dec
Bullous hematoma of the palm: an unusual complication of scabies in a child with congenital prothrombin deficiency.
2002 Nov-Dec
Diagnosis and treatment of scabies in 2002: rapid diagnosis and proper management limit the risk of spread.
2002 Oct
Characterization of an acyltransferase capable of synthesizing benzylbenzoate and other volatile esters in flowers and damaged leaves of Clarkia breweri.
2002 Sep
Acaricidal activity of Uvaria versicolor and Uvaria Klaineana (Annonaceae).
2003 Apr
Gland cell cultures into 3D hyaluronan-based scaffolds.
2003 Aug
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
2003 Feb 12
Understanding scabies.
2003 Feb 18-24
Acaricidal activity of Cnidium officinale rhizome-derived butylidenephthalide against Tyrophagus putrescentiae (Acari: Acaridae).
2003 Jan
Atovaquone-loaded nanocapsules: influence of the nature of the polymer on their in vitro characteristics.
2003 Jan 2
Autologous human keratinocytes cultured on membranes composed of benzyl ester of hyaluronic acid for grafting in nonhealing diabetic foot lesions: a pilot study.
2003 Jul-Aug
Molecular markers of anthropogenic activity in sediments of the Havel and Spree Rivers (Germany).
2003 Jun
Estrogenic activity of tissue conditioners in vitro.
2003 Jun
Pd/C-catalyzed chemoselective hydrogenation in the presence of a phenolic MPM protective group using pyridine as a catalyst poison.
2003 Mar
Quantitative fluorescence of 5-FU-treated fetal rat limbs using confocal laser scanning microscopy and Lysotracker Red.
2003 May
Potential cncer chemopreventive flavonoids from the stems of Tephrosia toxicaria.
2003 Sep
The efficacy of benzyl benzoate sprays in killing the storage mite Tyrophagus putrescentiae (Acari: Acaridae).
2004
In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability.
2004 Dec 15
Design, synthesis, and photochemical behavior of poly(benzyl ester) dendrimers with azobenzene groups throughout their architecture.
2004 Dec 24
Acaricidal activity of Paeonia suffruticosa root bark-derived compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
2004 Dec 29
Synthesis and characterization of branched poly(L-glutamic acid) as a biodegradable drug carrier.
2004 Jan 8
[Nosocomial infection of scabies in national hospitals and sanatoria in Japan].
2004 Jul
Phytochemistry and preliminary biological evaluation of Cyathostemma argenteum, a malaysian plant used traditionally for the treatment of breast cancer.
2004 Jul
Effects of sarcoptic mange and its control with oil of Cedrus deodara, Pongamia glabra, Jatropha curcas and benzyl benzoate, both with and without ascorbic acid on growing sheep: assessment of weight gain, liver function, nutrient digestibility, wool production and meat quality.
2004 Mar
Effects of sarcoptic mange and its control with oil of Cedrus deodara, Pongamia glabra, Jatropha curcas and benzyl benzoate, both with and without ascorbic acid on growing sheep: epidemiology; assessment of clinical, haematological, cell-mediated humoral immune responses and pathology.
2004 Mar
p-Anisaldehyde: acaricidal component of Pimpinella anisum seed oil against the house dust mites Dermatophagoides farinae and Dermatophagoides pteronyssinus.
2004 Mar
Controlled release of a model protein lysozyme from phase sensitive smart polymer systems.
2004 Mar 1
Synthesis of [323]-p-octiphenyls: orthogonal functionalization along a rigid-rod scaffold for refined supramolecular architecture.
2004 Mar 18
Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of sarcoptes scabiei var hominis to terpinen-4-ol.
2004 May
Acaricidal activity of constituents identified in Foeniculum vulgare fruit oil against Dermatophagoides spp. (Acari: Pyroglyphidae).
2004 May 19
Rapid and sensitive quantitative analysis of alkyl phosphates in urine after organophosphate poisoning.
2004 May-Jun
Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting.
2004 Nov
Cytocompatibility and viscoelastic properties of phthalate ester-free tissue conditioners.
2004 Sep
Efficacy of various synthetic pyrethroid-impregnated encasement materials against house dust mite under laboratory conditions.
2005
In vitro release of levonorgestrel from phase sensitive and thermosensitive smart polymer delivery systems.
2005
Floral scent emission and pollinator attraction in two species of Gymnadenia (Orchidaceae).
2005 Feb
Immunobiological [correction of Immunobioloical] activity of a new benzyl benzoate from the aerial parts of Solidago virga-aurea var. gigantea.
2005 Jan
Structure formation in injectable poly(lactide-co-glycolide) depots. II. Nature of the gel.
2005 Jan 15
Oligonucleotides conjugated to short lysine chains.
2005 Jul-Aug
Food protective effect of acaricidal components isolated from anise seeds against the stored food mite, Tyrophagus putrescentiae (Schrank).
2005 Jun
SAR studies of brasilicardin A for immunosuppressive and cytotoxic activities.
2005 Mar 1
Controlled delivery of testosterone from smart polymer solution based systems: in vitro evaluation.
2005 May 13
Anti-cancer ProTides: tuning the activity of BVDU phosphoramidates related to thymectacin.
2005 May 2
Deazapurine solid-phase synthesis: combinatorial synthesis of a library of N3,N5,C6-trisubstituted pyrrolo[3,2-d]pyrimidine derivatives on cross-linked polystyrene bearing a cysteamine linker.
2005 Nov-Dec
Effect of co-solvents on the controlled release of calcitonin polypeptide from in situ biodegradable polymer implants.
2005 Nov-Dec
Structure-activity studies of 3'-4'-dichloro-meperidine analogues at dopamine and serotonin transporters.
2005 Oct 1
Free radical generation during chemical depolymerization of heparin.
2005 Sep 15
Patents

Sample Use Guides

30 mL of the lotion usually is sufficient for one application in adults and 20 mL usually is sufficient in children. The patient should bathe 24–48 hours after the last application to remove the drug.
Route of Administration: Topical
no mites were alive after 3 h exposure to 25% benzyl benzoate (Ascabiol)
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:13:30 GMT 2023
Edited
by admin
on Fri Dec 15 15:13:30 GMT 2023
Record UNII
N863NB338G
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Benzyl benzoate
EP   FCC   FHFI   HSDB   II   INCI   MART.   MI   ORANGE BOOK   USP   USP-RS   VANDF   WHO-DD   WHO-IP  
INCI  
Official Name English
SCABIOZON
Common Name English
BENZYL BENZOATE [EP IMPURITY]
Common Name English
BENZYL BENZOATE [MART.]
Common Name English
BENZYL BENZOATE [USP-RS]
Common Name English
BENZYL BENZOATE [USP MONOGRAPH]
Common Name English
BENZOIC ACID, BENZYL ESTER
Common Name English
Benzyl benzoate [WHO-DD]
Common Name English
BENZYLIS BENZOAS [WHO-IP LATIN]
Common Name English
NSC-8081
Code English
BENZYL BENZOATE [II]
Common Name English
VENZONATE
Common Name English
BENZYL BENZOATE [ORANGE BOOK]
Common Name English
BENZYLOXY PHENYL KETONE
Systematic Name English
BENZYL BENZOATE [HSDB]
Common Name English
PHENYLMETHYL BENZOATE
Systematic Name English
BENZYL BENZOATE [INCI]
Common Name English
BENZYL BENZOATE [USP IMPURITY]
Common Name English
BENZYL BENZOATE [MI]
Common Name English
BENZYL BENZOATE [FHFI]
Common Name English
BENZYL BENZOATE [EP MONOGRAPH]
Common Name English
BENZYL BENZOATE [FCC]
Common Name English
BENZYL BENZOATE [WHO-IP]
Common Name English
BENZYLBENZENECARBOXYLATE
Systematic Name English
BENZYL BENZOATE [JAN]
Common Name English
Classification Tree Code System Code
CFR 21 CFR 172.515
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
WHO-ATC P03AX01
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
EC SCIENTIFIC COMMITTEE ON CONSUMER SAFETY OPINION SCCS/1459/11
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
WHO-ESSENTIAL MEDICINES LIST 13.5
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
JECFA EVALUATION BENZYL BENZOATE
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
EPA PESTICIDE CODE 9501
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
WHO-VATC QP53AX11
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
Code System Code Type Description
EVMPD
SUB13023MIG
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
ECHA (EC/EINECS)
204-402-9
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
EPA CompTox
DTXSID8029153
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
MERCK INDEX
m2400
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY Merck Index
NSC
8081
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
CAS
120-51-4
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
ChEMBL
CHEMBL1239
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
ALANWOOD
benzyl benzoate
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
JECFA MONOGRAPH
309
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
PUBCHEM
2345
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
HSDB
208
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
FDA UNII
N863NB338G
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
NCI_THESAURUS
C65255
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
RS_ITEM_NUM
1062008
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
SMS_ID
100000091327
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
MESH
C006723
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
CHEBI
41237
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
WHO INTERNATIONAL PHARMACOPEIA
BENZYL BENZOATE
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY Description: A clear, colourless, oily liquid; odour, faintly aromatic. Miscibility: Practically immiscible with water and glycerol R; miscible with ethanol (~750 g/l) TS and ether R. Category: Scabicide (topical use). Storage: Benzyl benzoate should be kept in a tightly closed and well-filled container, protected from light. Additional information: Benzyl benzoate may slowly decompose on contact with air. Definition: Benzyl benzoate contains not less than 98.0% and not more than 100.5% of C14H12O2.
DRUG CENTRAL
335
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
WIKIPEDIA
BENZYL BENZOATE
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
RXCUI
19044
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY RxNorm
DRUG BANK
DB00676
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
DAILYMED
N863NB338G
Created by admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT MAY BE PRESENT
ASSAY (GC)
Related Record Type Details
PARENT -> IMPURITY
Related Record Type Details
ACTIVE MOIETY
http://apps.who.int/phint/pdf/b/Jb.6.1.51.pdf